Global development EAs were very much looking into vaccines around 2015 and then and now it seemed that the malaria vaccine is just not crazy cost-effective, because you have to administer it more than once and it’s not 100% effective—see
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis
Current theme: default
Less Wrong (text)
Less Wrong (link)
Arrow keys: Next/previous image
Escape or click: Hide zoomed image
Space bar: Reset image size & position
Scroll to zoom in/out
(When zoomed in, drag to pan; double-click to close)
Keys shown in yellow (e.g., ]) are accesskeys, and require a browser-specific modifier key (or keys).
]
Keys shown in grey (e.g., ?) do not require any modifier keys.
?
Esc
h
f
a
m
v
c
r
q
t
u
o
,
.
/
s
n
e
;
Enter
[
\
k
i
l
=
-
0
′
1
2
3
4
5
6
7
8
9
→
↓
←
↑
Space
x
z
`
g
Global development EAs were very much looking into vaccines around 2015 and then and now it seemed that the malaria vaccine is just not crazy cost-effective, because you have to administer it more than once and it’s not 100% effective—see
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis